Other Ticker:  
    Sector     Industry
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 207
 Employees -
 Revenues (TTM) (Millions $) 4,081
 Net Income (TTM) (Millions $) 491
 Cash Flow (TTM) (Millions $) 537
 Capital Exp. (TTM) (Millions $) 105



Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

The ascending corporation from the market the SVVC reported the financial span ending third quarter of 2023, earnings

The sector experts continue to interpret the third quarter of 2023 numbers. Today those experts follow operating deficit of $-0.400487 million, from the , which has not mentioned any revenue yet, for the respective July to September 30 2023 financial reporting period.

The company reported operating deficit in the second quarter of 2023

The stockholders have not anticipated any adjustments at the top-line all over the earnings season of the April to June 30 2023 at the company. But, they pay very near attention to AEONs' operating deficit which has been at $-3.526521 million, in the same period.

The company announced operating loss in the third quarter of 2023

The stockholders haven't expected any modifications at the top-line all over the July to September 30 2023 reporting season at the company. But, investors monitor HTFCs' operating loss that has been at $-4.057 million, during the matching time.

Breaking down fourth quarter of 2023 numbers, the company's had that the company went from strength to strength

In the wake of notable Revenue advance of 55846.958 % year on year to $3.45 billion in its April to June 30 2023, s' earnings turned positive at $0.54. NAs' thrives in the fourth quarter of 2023, as greater number of the companies in the industries are enduring headwinds with the Receding businesses and facing retracting revenue.

The company created some good surprise for the investors, posting a genuine gain in fourth quarter of 2023 with operating deficit of $-9.696 million

Following the big players in the industry, a few overlooked businesses are impending with the earnings. said it has booked operating deficit of $-9.696 million, for the fourth quarter of 2023.


's Segments
Infection Prevention
 Segment     of total Revenue
Medical Specialties
 Segment     of total Revenue
Specialty Disposables
 Segment     of total Revenue
Total Procedural Solutions
 Segment     of total Revenue
Dispensing Technologies
 Segment     of total Revenue
Infusion Systems
 Segment     of total Revenue
Respiratory Technologies
 Segment     of total Revenue
Other Medical Systems
 Segment     of total Revenue
Total Medical Systems
 Segment     of total Revenue
• View Complete Report
  Company Estimates  
  Revenue Outlook
does not provide revenue guidance.

Earnings Outlook
does not provide earnings estimates.

Geographic Revenue Dispersion
United States


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com